Wells Fargo notes that Clinicaltrials.gov lists Penumbra’s THUNDER trial as having reduced the total enrollment number to 216 from 275 as of October 16, so when Penumbra announc ...
News about one of Penumbra's (NYSE: PEN) development programs and an analyst's price target raise combined to boost the medical device company's stock on Monday. Its price rose by over 4% ...
In its 48 years of presenting theater works rooted in the experiences of African-Americans, Penumbra Theatre’s linchpin relationship has been with playwright August Wilson. But the company has ...
On Friday, Penumbra Inc . (NYSE:PEN), a global healthcare company, saw its price target increased by Piper Sandler from $220.00 to $225.00. The firm maintained an Overweight rating on the stock ...